Publications

Fibroids, or uterine leiomyomas, represent a prevalent gynecological condition impacting women of reproductive age worldwide. Transforming Growth Factor-Beta (TGF-β) emerges as a critical mediator in the intricate landscape of fibroid development and progression. This abstract encapsulates a comprehensive review elucidating the multifaceted roles of TGF-β in the context of fibroid pathogenesis, encompassing molecular mechanisms and clinical implications. The TGF-β superfamily, comprising TGF-β isoforms (TGF-β1, TGF-β2, and TGF-β3), orchestrates diverse cellular responses governing cell proliferation, differentiation, and extracellular matrix remodeling. Dysregulated TGF-β signaling pathways contribute significantly to fibroid initiation and maintenance by promoting aberrant cellular proliferation, apoptosis resistance, and altered extracellular matrix composition within the uterine tissue. This paper consolidates current knowledge, highlighting the distinct contributions of TGF-β isoforms to fibroid pathophysiology. Enhanced TGF-β expression and downstream signaling dysregulation foster a microenvironment conducive to fibroid growth and progression. Insights into the pivotal role of TGF-β in fibroid pathogenesis open avenues for novel therapeutic modalities aimed at modulating TGF-β signaling cascades. Targeted strategies involving TGF-β inhibitors or modulation of downstream effectors hold promise for innovative treatments in fibroid management. In conclusion, this abstract provides a synopsis of the integral involvement of TGF-β in driving fibroid progression. Understanding the intricate molecular mechanisms underlying TGF-β signaling offers a foundation for novel therapeutic avenues and diagnostic advancements, fostering improved management strategies for this prevalent women's health concern. Continued research into TGF-β-mediated pathways is paramount for enhancing our understanding and clinical management of fibroids.